ImpediMed Limited at it's general meeting approved removal of Donald Williams as a director of the Company, removal of Amit Patel as a director of the Company, removal of David Anderson as a director of the Company, removal of Daniel Sharp as a director of the Company with effect from September 28, 2023, appointment of McGregor Grant as a director of the Company with effect from September 28, 2023, appointment of Christine Emmanuel-Donnelly as a director of the Company, appointment of Andrew Grant as a director of the Company and appointment of Janelle Delaney as a director of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.088 AUD | +4.76% | +12.82% | -39.31% |
30/04 | ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8% | MT |
30/04 | Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-39.31% | 114M | |
+12.50% | 229B | |
+14.52% | 195B | |
+17.51% | 142B | |
+28.96% | 109B | |
+3.27% | 64.85B | |
+18.16% | 54.33B | |
+7.63% | 52.09B | |
+10.95% | 45.15B | |
+5.10% | 37.39B |
- Stock Market
- Equities
- IPD Stock
- News ImpediMed Limited
- Impedimed Limited Announces Board Changes